[Skip to Content]
Sign In
Individual Sign In
Create an Account
Institutional Sign In
OpenAthens Shibboleth
[Skip to Content Landing]
Views 303
Citations 0
Correction
November 14, 2019

Failure to Disclose a Potential Conflict of Interest

JAMA Oncol. Published online November 14, 2019. doi:https://doi.org/10.1001/jamaoncol.2019.5468

In the Original Investigation titled “Assessment of Lung Cancer Risk on the Basis of a Biomarker Panel of Circulating Proteins,”1 published in JAMA Oncology online first on July 12, 2018, and with the October 2018 issue, a potential conflict of interest was not reported. Three of the authors, Drs Taguchi, Feng, and Hanash, had filed a patent, Methods for the Detection and Treatment of Lung Cancer (WO2018148600), based on the data included in this article.2 This article was corrected online. This article was also corrected on September 13, 2018, for an error in an author surname.

References
1.
Guida  F, Sun  N, Bantis  LE,  et al; Integrative Analysis of Lung Cancer Etiology and Risk (INTEGRAL) Consortium for Early Detection of Lung Cancer.  Assessment of lung cancer risk on the basis of a biomarker panel of circulating proteins.  JAMA Oncol. 2018;4(10):e182078. doi:10.1001/jamaoncol.2018.2078PubMedGoogle Scholar
2.
Hanash  S, Feng  Z, Taguchi  A.  Letter of explanation—failure to disclose potential conflict of interest  [published online November 14, 2019].  JAMA Oncol. doi:10.1001/jamaoncol.2019.5259Google Scholar
×